Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss KELOWNA, BC / ACCESS Newswire / April 3, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or ...

Cannabis is more than just a recreational indulgence—it’s a powerhouse of wellness, sustainability, and industry. From hemp’s ...

The U.S. Supreme Court ruled on Wednesday against Medical Marijuana Inc in its bid to fend off a lawsuit by a commercial ...

Douglas Horn suffered chronic back and shoulder pain. Medical Marijuana, Inc., sold him a CBD product known as “Dixie X” and said it contained no THC.

UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...

The path forward for a medical cannabis bill in the Nebraska Legislature appears more uncertain after a committee chair tasked his members with deciding what medical conditions would ...

By a 5-4 vote, the U.S. Supreme Court refused to read the RICO statute to bar claims that involve a personal injury—a win for ...

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...

Ananda Pharma PLC announced on Wednesday that it had received approval for the phase 1 pharmacokinetic study of its lead investigational cannabidiol drug candidate, MRX1, in Australia. The ...

By a 5-4 vote, the U.S. Supreme Court refused to read the RICO statute to bar claims that involve a personal injury—a win for a trucker fired for taking a cannabidiol product he thought was free of ...